Clinical Trial Update: A Phase 2, Multicenter Open-Label Extension (OLE) Study With ABT-122 in Active Psoriatic Arthritis Subjects Who Have Completed a Preceding Study M14-197 [Phase 2]

View source ↗

Summary

This clinical trial update notes that the Phase 2 open-label extension of ABT-122 in active psoriatic arthritis subjects who completed study M14-197 has been te…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis

Drugs mentioned

• ABT-122

Snippet

Sponsor: AbbVie | Conditions: Psoriatic Arthritis | Phase 2 | Status: TERMINATED